Knowledge Hub

Research Announces: T2 Biosystems, Inc. (TTOO) - Product Pipeline Analysis, 2016 Update

Press release   •   Jul 07, 2016 07:12 EDT

T2 Biosystems, Inc. (T2 Biosystems) is a medical device company that develops clinical diagnostic products in the field of in vitro diagnostics. The companys T2 magnetic resonance technology allows direct detection in complex samples, such as whole blood, serum, plasma, sputum and urine. It offers T2 magnetic resonance instruments, including T2Candida, T2Lyme Panel, T2Bacteria, and T2Hemostatis. T2 Biosystems T2MR detection technology is a biosensor technology, that provides rapid diagnostic results with minimal and no sample preparation. The companys T2Candida product provides species-specific identification directly from whole blood. It provides hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Download Sample copy of this Report at :


- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company T2 Biosystems, Inc.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Browse Blog At :

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

T2 Biosystems, Inc. Company Snapshot 6

T2 Biosystems, Inc. Company Overview 6

T2 Biosystems, Inc. Pipeline Products and Clinical Trials Overview 7

T2 Biosystems, Inc. Pipeline Analysis Overview 9

Key Facts 9

T2 Biosystems, Inc. - Major Products and Services 10

T2 Biosystems, Inc. Pipeline Products by Development Stage 11

T2 Biosystems, Inc. Pipeline Products Overview 13

T2Bacteria 13

T2Bacteria Product Overview 13

T2Dx - Cancer 14

T2Dx - Cancer Product Overview 14

T2Dx - Cardiac 15

T2Dx - Cardiac Product Overview 15

T2Endotoxin 16

T2Endotoxin Product Overview 16

T2HemoStat 17

T2HemoStat Product Overview 17

T2Plex 18

T2Plex Product Overview 18

T2 Biosystems, Inc. - Key Competitors 19

T2 Biosystems, Inc. - Key Employees 20

T2 Biosystems, Inc. - Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Recent Developments 22

T2 Biosystems, Inc., Recent Developments 22

Jun 02, 2016: Study Published in the American Journal of Clinical Pathology Demonstrates T2Candida Panel Provides Rapid and Accurate Diagnosis of Candida, a Leading Cause of Sepsis, in Pediatric Patients 22

May 02, 2016: T2 Biosystems Reports 2016 First Quarter Results 22

Apr 11, 2016: T2 Biosystems Announces Preliminary 2016 First Quarter Financial Results 23

Feb 16, 2016: T2 Biosystems Reports 2015 Fourth Quarter, Full Year Results 24

Nov 04, 2015: Study Results Demonstrate T2Bacteria Panel Achieves Rapid and Sensitive Detection of Six Clinically-Relevant Bacteria Species Directly From Whole Blood 26

Nov 03, 2015: T2 Biosystems Appoints Chief Commercial Officer 27

Nov 02, 2015: T2 Biosystems Reports 2015 Third Quarter Results 27

Oct 29, 2015: T2 Biosystems Announces Leading Hospitals Adopting T2Candida for Sepsis Detection 28

Oct 28, 2015: T2 Biosystems' T2Candida Panel Named Best Medical Technology Product at Prix Galien USA Awards 28

Sep 19, 2015: Study Demonstrates T2Candida Panel is More Sensitive and Rapid Than Blood Culture at Identifying Invasive Infections 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30 is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.